Home

FHM VII, L.P.

CIK 1654632 · last filed 2021-07-20

FHM VII, L.P. is a corporate insider who has filed 2 SEC Form 4 insider transactions across 2 companies since 2017. The most recent filing, for IMGO, was dated Jul 20, 2021. Across all open-market trades the lifetime net is +$63.0M, making them a net buyer over the disclosed history. Current disclosed insider exposure totals $73.8M across reported positions. The firm reports its address in Seattle, WA. 9 SEC filings were submitted jointly with Frazier Healthcare VII, L.P.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$73.79M

Companies

2

Total Filings

2

Lifetime Open-Market Net

$63.00M

Filer Profile

Reported Address
C/O FRAZIER HEALTHCARE
601 UNION STREET, SUITE 3200
SEATTLE, WA 98101
Phone
(206) 621-7200
State of Incorporation
DE
Related Filers
Frazier Healthcare VII, L.P. — 9 joint filings, latest 2021-07-20
Frazier Healthcare VII-A, L.P. — 9 joint filings, latest 2021-07-20
Patrick J Heron — 8 joint filings, latest 2021-07-20
ANAPTYSBIO, INC — 4 joint filings, latest 2018-05-15
Nathan R Every — 4 joint filings, latest 2018-05-15
ALAN D FRAZIER — 4 joint filings, latest 2018-05-15
Nader J Naini — 4 joint filings, latest 2018-05-15
Profile details as reported on the filer's SEC submissions — for individual insiders the address is often in care of the issuer. Related filers are identified from jointly filed SEC submissions and shared reported addresses. View filings on SEC EDGAR.

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
Imago BioSciences, Inc. (IMGO) Delisted 10%+ Owner 145,918 $36.01 $5.25M $15.00M 1 2021-07-20
ANAB 10%+ Owner 1,337,795 $55.16 $73.79M $48.00M 1 2017-01-31

Recent Filings

2 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2021-07-20 Imago BioSciences, Inc. (IMGO) Delisted Mixed +14,856,370 $15.00M EDGAR
2017-01-31 ANAB Mixed +28,569,696 $48.00M EDGAR
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.